Bone Diseases Clinical Trials

A listing of Bone Diseases medical research trials actively recruiting patient volunteers. Click on the closest city to find more detailed information on a research study in your area.

 

Alabama

Birmingham Alabama 35235

A Phase 3 clinical study for patients with Degenerative Disc Disease

Arizona

Scottsdale Arizona 85258

A Phase 3 clinical study for patients with Degenerative Disc Disease

California

Pasadena California 91105

A Phase 3 clinical study for patients with Degenerative Disc Disease

Redwood City California 94063

Patients are needed to participate in a clinical research study evaluating Photodynamic Bone Stabilization System (PBSS) for the treatment of Humerus Pathological Fracture

Sacramento California 95816

A Phase 3 clinical study for patients with Degenerative Disc Disease

Santa Monica California 90403

A Phase 3 clinical study for patients with Degenerative Disc Disease

Torrance California 90502

Patients are needed to participate in a clinical research study evaluating Photodynamic Bone Stabilization System (PBSS) for the treatment of Humerus Pathological Fracture

View More ▼

Walnut Creek California 94598

A Phase 3 clinical study for patients with Degenerative Disc Disease

Colorado

Greenwood Village Colorado 80111

A Phase 3 clinical study for patients with Degenerative Disc Disease

District of Columbia

Washington District of Columbia 20037

A Phase 3 clinical study for patients with Degenerative Disc Disease

Washington District of Columbia 20010

Patients are needed to participate in a clinical research study evaluating Photodynamic Bone Stabilization System (PBSS) for the treatment of Humerus Pathological Fracture

Florida

Arthritis and Rheumatic Disease Specialities
Aventura Florida 33180

A Phase III, Randomized, Double-blind, Placebo-controlled Study of Subcutaneous Secukinumab in Autoinjectors, to Demonstrate Efficacy at 24 Weeks and Long Term Safety and Efficacy up to 3.5 Years in Subjects With Active Psoriatic Arthritis

Center for Arthritis and Rheumatic Diseases
Miami Florida 33173

A Phase III, Randomized, Double-blind, Placebo-controlled Study of Subcutaneous Secukinumab in Autoinjectors, to Demonstrate Efficacy at 24 Weeks and Long Term Safety and Efficacy up to 3.5 Years in Subjects With Active Psoriatic Arthritis

Arthritis Center
Palm Harbor Florida 34684

A Phase III, Randomized, Double-blind, Placebo-controlled Study of Subcutaneous Secukinumab in Autoinjectors, to Demonstrate Efficacy at 24 Weeks and Long Term Safety and Efficacy up to 3.5 Years in Subjects With Active Psoriatic Arthritis

Sarasota Arthritis Research Center
Sarasota Florida 34239

A Phase III, Randomized, Double-blind, Placebo-controlled Study of Subcutaneous Secukinumab in Autoinjectors, to Demonstrate Efficacy at 24 Weeks and Long Term Safety and Efficacy up to 3.5 Years in Subjects With Active Psoriatic Arthritis

Florida Medical Clinic PA
Zephyrhills Florida 33542

A Phase III, Randomized, Double-blind, Placebo-controlled Study of Subcutaneous Secukinumab in Autoinjectors, to Demonstrate Efficacy at 24 Weeks and Long Term Safety and Efficacy up to 3.5 Years in Subjects With Active Psoriatic Arthritis

View More ▼

Fort Lauderdale Florida 33314 and 33133

Patients are needed to participate in a clinical research study evaluating Photodynamic Bone Stabilization System (PBSS) for the treatment of Humerus Pathological Fracture

Oakland Park Florida 33334

A Phase 3 clinical study for patients with Degenerative Disc Disease

Georgia

Atlanta Georgia 30329

A Phase 3 clinical study for patients with Degenerative Disc Disease

Atlanta Georgia 30329

Patients are needed to participate in a clinical research study evaluating Photodynamic Bone Stabilization System (PBSS) for the treatment of Humerus Pathological Fracture

Illinois

Deerbrook Medical Associates
Vernon Hills Illinois 60061

A Phase III, Randomized, Double-blind, Placebo-controlled Study of Subcutaneous Secukinumab in Autoinjectors, to Demonstrate Efficacy at 24 Weeks and Long Term Safety and Efficacy up to 3.5 Years in Subjects With Active Psoriatic Arthritis

View More ▼

Bloomington Illinois 61701

A Phase 3 clinical study for patients with Degenerative Disc Disease

Chicago Illinois 60612

Patients are needed to participate in a clinical research study evaluating Photodynamic Bone Stabilization System (PBSS) for the treatment of Humerus Pathological Fracture

Indiana

Dawes-Fretzin Clinical Research
Indianapolis Indiana 46256

A Phase III, Randomized, Double-blind, Placebo-controlled Study of Subcutaneous Secukinumab in Autoinjectors, to Demonstrate Efficacy at 24 Weeks and Long Term Safety and Efficacy up to 3.5 Years in Subjects With Active Psoriatic Arthritis

Kentucky

Graves Gilbert Clinic
Bowling Green Kentucky 42101

A Phase III, Randomized, Double-blind, Placebo-controlled Study of Subcutaneous Secukinumab in Autoinjectors, to Demonstrate Efficacy at 24 Weeks and Long Term Safety and Efficacy up to 3.5 Years in Subjects With Active Psoriatic Arthritis

View More ▼

Edgewood Kentucky 41017

A Phase 3 clinical study for patients with Degenerative Disc Disease

Louisiana

Shreveport Louisiana 71103

A Phase 3 clinical study for patients with Degenerative Disc Disease

Maryland

Baltimore Maryland 21237

Patients are needed to participate in a clinical research study evaluating Photodynamic Bone Stabilization System (PBSS) for the treatment of Humerus Pathological Fracture

Minnesota

Shakopee Minnesota 55379

A Phase 3 clinical study for patients with Degenerative Disc Disease

Mississippi

Tupelo Mississippi 38801

Patients are needed to participate in a clinical research study evaluating Photodynamic Bone Stabilization System (PBSS) for the treatment of Humerus Pathological Fracture

Missouri

Clayton Medical Research
St. Louis Missouri 63117

A Phase III, Randomized, Double-blind, Placebo-controlled Study of Subcutaneous Secukinumab in Autoinjectors, to Demonstrate Efficacy at 24 Weeks and Long Term Safety and Efficacy up to 3.5 Years in Subjects With Active Psoriatic Arthritis

Montana

Butte Montana 59701

A clinical trial seeking patients for a research study for the treatment of Bone Diseases, Infectious

New Jersey

Arthritis and Osteoporosis Associates
Freehold New Jersey 07728

A Phase III, Randomized, Double-blind, Placebo-controlled Study of Subcutaneous Secukinumab in Autoinjectors, to Demonstrate Efficacy at 24 Weeks and Long Term Safety and Efficacy up to 3.5 Years in Subjects With Active Psoriatic Arthritis

View More ▼

Hackensack New Jersey 07601

Patients are needed to participate in a clinical research study evaluating Photodynamic Bone Stabilization System (PBSS) for the treatment of Humerus Pathological Fracture

New York

The Center for Rheumatology
Albany New York 12206

A Phase III, Randomized, Double-blind, Placebo-controlled Study of Subcutaneous Secukinumab in Autoinjectors, to Demonstrate Efficacy at 24 Weeks and Long Term Safety and Efficacy up to 3.5 Years in Subjects With Active Psoriatic Arthritis

View More ▼

New York New York 10021

Patients are needed to participate in a clinical research study evaluating Photodynamic Bone Stabilization System (PBSS) for the treatment of Humerus Pathological Fracture

North Carolina

Charlotte North Carolina 28204

A Phase 3 clinical study for patients with Degenerative Disc Disease

Durham North Carolina 27710

Patients are needed to participate in a clinical research study evaluating Photodynamic Bone Stabilization System (PBSS) for the treatment of Humerus Pathological Fracture

Winston-Salem North Carolina 27157

Patients are needed to participate in a clinical research study evaluating Photodynamic Bone Stabilization System (PBSS) for the treatment of Humerus Pathological Fracture

Ohio

Cleveland Ohio 44106

A Phase 3 clinical study for patients with Degenerative Disc Disease

Columbus Ohio 43214

Patients are needed to participate in a clinical research study evaluating NuCel and Deminaralized Bone Matrix for the treatment of Lumbar Degenerative Disc Disease

Columbus Ohio 43215

Patients are needed to participate in a clinical research study evaluating NuCel and Deminaralized Bone Matrix for the treatment of Lumbar Degenerative Disc Disease

Columbus Ohio 43210

Patients are needed to participate in a clinical research study evaluating Photodynamic Bone Stabilization System (PBSS) for the treatment of Humerus Pathological Fracture

Oklahoma

Edmond Oklahoma 73013

A Phase 3 clinical study for patients with Degenerative Disc Disease

Pennsylvania

Pittsburgh Pennsylvania 15232

Patients are needed to participate in a clinical research study evaluating Photodynamic Bone Stabilization System (PBSS) for the treatment of Humerus Pathological Fracture

York Pennsylvania 17402

A Phase 3 clinical study for patients with Degenerative Disc Disease

Rhode Island

Providence Rhode Island 02903

A Phase 3 clinical study for patients with Degenerative Disc Disease

Providence Rhode Island 02905

Patients are needed to participate in a clinical research study evaluating Photodynamic Bone Stabilization System (PBSS) for the treatment of Humerus Pathological Fracture

South Carolina

Charleston South Carolina 29406

A Phase 3 clinical study for patients with Degenerative Disc Disease

Texas

Austin Regional Clinic Rheumatology
Austin Texas 78731

A Phase III, Randomized, Double-blind, Placebo-controlled Study of Subcutaneous Secukinumab in Autoinjectors, to Demonstrate Efficacy at 24 Weeks and Long Term Safety and Efficacy up to 3.5 Years in Subjects With Active Psoriatic Arthritis